Keywords: galapagos, enters, 1m, cf, drug, discovery, accord
Galapagos enters $8.1M CF drug discovery accord
Article | 03 December 2007
Belgian drug discovery Galapagos NV and Cystic Fibrosis Foundation Therapeutics, a non-profit affiliate of the USA-based Cystic Fibrosis Foundation, have ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
